Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL4039880

COc1ccc(CCl)c(OC)c1.N.[H+]

nearest known ligand 0.59

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APLNR P35414 1/20 0.59
CA2 P00918 2/20 0.52
CA12 O43570 1/20 0.52
CA1 P00915 1/20 0.52
CA7 P43166 1/20 0.52
CA9 Q16790 1/20 0.52
CA14 Q9ULX7 1/20 0.52
ALDH1A1 P00352 4/20 0.46
GFER P55789 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP1A1 P04798 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP1B1 Q16678 1/20 0.46
MAPT P10636 1/20 0.45
IDO1 P14902 2/20 0.44
ADRA1A P35348 1/20 0.44
TAAR1 Q96RJ0 1/20 0.44
DYRK1A Q13627 1/20 0.44
TSHR P16473 1/20 0.43
HTR2A P28223 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL590943 0.96 APLNR (0.63) APLNRCA2CA12CA1CA7
SCHEMBL1055293 0.80 IDO1 (0.61) APLNRCA2CA12CA1CA7
Ammonia Solution, Strong SCHEMBL266597 0.80 APLNR (0.63) APLNRCA2CA12CA1CA7
SCHEMBL145084 0.79 APLNR (0.68) APLNRCA2CA12CA1CA7
SCHEMBL9676713 0.79 ALDH1A1 (0.51) APLNRCA2CA12CA1CA7
Methylene Chloride SCHEMBL28212226 0.79 APLNR (0.58) APLNRCA2CA12CA1CA7
Methylene Chloride SCHEMBL28275708 0.79 APLNR (0.58) APLNRCA2CA12CA1CA7
SCHEMBL11575891 0.79 SLC6A4 (0.50) APLNRCA2CA12CA1CA7
SCHEMBL489792 0.78 ALDH1A1 (0.47) APLNRCA2CA12CA1CA7
Bromide SCHEMBL27566990 0.78 IDO1 (0.59) APLNRCA2CA12CA1CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1066286-B1 HETEROCYCLO-SUBSTITUTED IMIDAZOPYRAZINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2009-04-29 EP disclosed
EP-1066286-A4 HETEROCYCLO-SUBSTITUTED IMIDAZOPYRAZINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2004-02-11 EP disclosed
EP-1066286-A1 HETEROCYCLO-SUBSTITUTED IMIDAZOPYRAZINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2001-01-10 EP disclosed
US-5990109-A NOVEL COMPOUNDS, METHODS OF THEIR SYNTHESIS, AND THEIR USE IN TREATING VARIOUS TYROSINE KINASE-ASSOCIATED IMMUNOLOGICAL DISORDERS, SUCH AS RHEUMATOID ARTHRITIS, MULTIPLE SCLEROSIS, GRAFT VS. HOST DISEASE, LUPUS, PSORIASIS AND ASTHMA BRISTOL-MYERS SQUIBB CO. (US) 1999-11-23 US disclosed
WO-1999045009-A1 HETEROCYCLO-SUBSTITUTED IMIDAZOPYRAZINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-09-10 WO disclosed